Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Power Morcellator Lawsuit News: New Study Finds Doctors Cannot Detect Uterine Sarcoma Before Power Morcellation Surgery, The Oliver Law Group P.C. Comments
  • USA - English


News provided by

The Oliver Law Group

Feb 02, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

If you’ve been harmed, learn more about filing a Power Morcellator lawsuit. Contact The Oliver Law Group for your FREE case review by calling 1-800-939-7878 or visit www.legalactionnow.com
If you’ve been harmed, learn more about filing a Power Morcellator lawsuit. Contact The Oliver Law Group for your FREE case review by calling 1-800-939-7878 or visit www.legalactionnow.com

If you’ve been harmed and would like to learn more about filing a Power Morcellator lawsuit contact The Oliver Law Group for your FREE case review by calling 1-800-939-7878 or visit www.legalactionnow.com

Post this

Chicago IL (PRWEB) February 02, 2015 -- Power Morcellator Lawsuit & Surgery News: A study published online by researchers from Kaiser Permanente found that it’s difficult for doctors to detect uterine cancer in fibroids prior to women having a hysterectomy or a myomectomy using a power morcellator. In their study published online by the American Journal of Obstetrics & Gynecology on December 11, 2014, the Kaiser researchers conducted a retrospective review of 3,523 women who underwent a hysterectomy (uterus removal) from 2001 to 2012. Included in the total number of patients, were 941 women who underwent a hysterectomy in which a power morcellator was used. Of the 941 women, 10 women, or 1.1 percent, were subsequently diagnosed with uterine sarcomas or parasitic myomas. Out of the 10 women, six patients had uterine sarcoma. Researchers suggest that women should be counseled about the potential cancer risks when a power morcellator is involved during surgery to remove fibroids.
[ajog.org/article/S0002-9378(14)02379-5/abstract?rss=yes, December 2014]

The study’s release comes nearly three weeks after the U.S. Food and Drug Administration (FDA) directed power morcellator manufacturers to add a black box warning, the FDA’s most serious warning, on the product labels of their medical devices to warn doctors and patients about the cancer risks associated with the morcellators, notes the Oliver Law Group. Laparoscopic power morcellators slice uterine fibroids and tissue into fragments so that the pieces can be removed through a small incision in the abdomen. According to the FDA, the undetected cancer cells spread as the tissue is removed from the abdomen. In a safety announcement in November, the FDA strongly advised doctors to discuss the cancer risks with their patients and recommended limiting certain patients from receiving laparoscopic morcellation surgery. While the FDA warned doctors against using the medical device, the federal agency did not ban the practice of using power morcellators to remove the uterus or uterine fibroids.
[http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm424435.htm?, November 24, 2014]

The FDA issued its first safety alert regarding power morcellators in April 2014, states the Oliver Law Group. In that statement, the federal regulatory agency noted the spreading of cancer during a morcellation procedure can quickly change the stage of cancer from stage 1 to stage 4, the final stage of cancer. According to a quantitative analysis conducted by the FDA based on currently available data, the FDA estimates that about 1 in 350 women who are undergoing a hysterectomy or myomectomy for fibroids has an unsuspected uterine sarcoma. There is a risk that the medical device will spread the cancerous tissue within the abdomen and pelvis, “significantly worsening the patient’s likelihood of long-term survival.” There is also a risk that the undetected cancer can include leiomyosarcoma, a rare but aggressive form of cancer that develops from smooth muscle tissue in the uterus and is spread by the power morcellator. After the FDA made its announcement in April, Reuters reported that Johnson & Johnson suspended global sales of power morcellators by its Ethicon Endo Surgery division until the company received further direction from the medical community and the FDA on the use of these medical devices.
[http://www.fda.gov/downloads/MedicalDevices/Safety/AlertsandNotices/UCM393589.pdf, FDA, April 17, 2014]
[reuters.com/article/2014/04/30/us-johnson-johnson-device-idUSKBN0DG06G20140430, April 30, 2014]

Court records indicate that women or their survivors are filing Power Morcellator lawsuits against power morcellator manufacturers. In one instance, a wrongful death Power Morcellator lawsuit was filed in December by the family of a Missouri woman who was diagnosed with cancer after she underwent surgery in which Ethicon’s Gynecare power morcellator was used. The lawsuit alleges that leiomyocarcoma was spread in the woman by the power morcellator that was used in the robotic hysterectomy the woman underwent in December 2012. According to the Power Morcellator lawsuit complaint, the woman underwent aggressive treatment for the cancer but she died of the malignant leiomyosarcoma in August 2014. The power morcellation lawsuit contends Ethicon knew or should have known about the cancer risks linked with the medical device and the company should have warned about the dangers associated with their power morcellator product. The lawsuit was filed on December 3 in the U.S. District Court, District of Western Missouri. (4:14-cv-01074)

“The issues causing litigation with this product used in surgery effecting women, comes on the heels of historic litigation relating to other medical products involving only women, such as transvaginal mesh used for pelvic organ prolapse and urinary incontinence,” states Alyson Oliver of the Oliver Law Group. The Oliver Law Group is involved in helping women who have been harmed due to the use of power morcellators in their surgery. If you’ve been harmed and would like to learn more about filing a Power Morcellator lawsuit, turn to the law firm with the Experience, Dedication, and Trust you deserve. Contact the law firm Oliver Law Group P.C. for your free case review by calling 1-800-939-7878 today or submitting your information through this site, http://www.legalactionnow.com

Contact Oliver Law Group P.C. To Learn More About Filing A Power Morcellator Lawsuit

The Oliver Law Group P.C. is a different kind of law firm. One that focuses on the needs of the injured first. A compassionate law firm dedicated to fighting for the rights of victims and their families, and doing everything necessary to ensure those rights.

The experience of a large firm. The 1-on-1 dedication of a small firm. A reputation built on trust.
Experience. Dedication. Trust. The Oliver Law Group P.C.

If you’ve been harmed and would like to learn more about filing a Power Morcellator lawsuit, turn to the law firm with the Experience, Dedication, and Trust you deserve. Contact The Oliver Law Group P.C. for your free case review by calling 1-800-939-7878 today or submitting your information through this site, http://www.legalactionnow.com

Alyson Oliver, The Oliver Law Group, http://www.legalactionnow.com, +1 800-939-7878, [email protected]

Modal title

If you’ve been harmed and would like to learn more about filing a Power Morcellator lawsuit contact The Oliver Law Group for your FREE case review by calling 1-800-939-7878 or visit www.legalactionnow
If you’ve been harmed and would like to learn more about filing a Power Morcellator lawsuit contact The Oliver Law Group for your FREE case review by calling 1-800-939-7878 or visit www.legalactionnow
If you’ve been harmed and would like to learn more about filing a Power Morcellator lawsuit contact The Oliver Law Group for your FREE case review by calling 1-800-939-7878 or visit www.legalactionnow

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.